Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Smoking

  Free Subscription


Articles published in Lancet

Retrieve available abstracts of 23 articles:
HTML format



Single Articles


    May 2022
  1. MCCALL C
    A smoke-free generation: New Zealand's tobacco ban.
    Lancet. 2022;399:1930-1931.
    PubMed    


  2. YACH D
    Tobacco harm reduction matters.
    Lancet. 2022;399:1864-1865.
    PubMed    


    April 2022
  3. HOPKINSON NS
    Medicinal licensing of e-cigarettes.
    Lancet. 2022;399:1602-1603.
    PubMed    


    January 2022
  4. JAUHAR S, Johnstone M, McKenna PJ
    Schizophrenia.
    Lancet. 2022;399:473-486.
    PubMed     Abstract available


    November 2021
  5. THE LANCET
    Tobacco control: far from the finish line.
    Lancet. 2021;398:1939.
    PubMed    


  6. JARDINE J, Walker K, Gurol-Urganci I, Webster K, et al
    Adverse pregnancy outcomes attributable to socioeconomic and ethnic inequalities in England: a national cohort study.
    Lancet. 2021 Nov 1. pii: S0140-6736(21)01595.
    PubMed     Abstract available


    July 2021
  7. KLEIN JD
    The nutrition agenda must include tobacco control.
    Lancet. 2021;398:300-301.
    PubMed    


    June 2021

  8. Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019.
    Lancet. 2021;397:2337-2360.
    PubMed     Abstract available


    February 2021
  9. FRANCEY N
    30th anniversary of Australian legal ruling on second-hand smoke.
    Lancet. 2021;397:466-467.
    PubMed    


    November 2020
  10. DAUBE M, Swanson M
    Conflicts of interest should be declared.
    Lancet. 2020;396:1561-1562.
    PubMed    


    August 2020
  11. POSCHENRIEDER F, Rotter M, Gschwendtner A, Hamer OW, et al
    E-cigarette-induced lung disease: from acute to chronic.
    Lancet. 2020;396:564.
    PubMed    


    June 2020
  12. ZAROCOSTAS J
    Plain packaging ruling hailed as a victory for tobacco control.
    Lancet. 2020;395:1895.
    PubMed    


    February 2020
  13. SHAHAB L, Britton J, Brown J, Hajek P, et al
    The need for an evidence-based and rational debate on e-cigarettes.
    Lancet. 2020;395:688.
    PubMed    


  14. XUE Y
    Smoking cessation programmes in China.
    Lancet. 2020;395:e28.
    PubMed    


    December 2019
  15. ALEXANDER LEC, Perez MF
    Identifying, tracking, and treating lung injury associated with e-cigarettes or vaping.
    Lancet. 2019;394:2041-2043.
    PubMed    


  16. BLAGEV DP, Harris D, Dunn AC, Guidry DW, et al
    Clinical presentation, treatment, and short-term outcomes of lung injury associated with e-cigarettes or vaping: a prospective observational cohort study.
    Lancet. 2019;394:2073-2083.
    PubMed     Abstract available


    November 2019
  17. JAFFE S
    Will Trump snuff out e-cigarettes?
    Lancet. 2019;394:1977-1978.
    PubMed    


  18. NEWTON JN
    Time for The Lancet to realign with the evidence on e-cigarettes?
    Lancet. 2019;394:1804-1805.
    PubMed    


  19. SALZMAN M
    Philip Morris International: time for a new conversation.
    Lancet. 2019;394:1711-1712.
    PubMed    


    October 2019
  20. THE LANCET
    E-cigarettes: time to realign our approach?
    Lancet. 2019;394:1297.
    PubMed    


    September 2019
  21. LI X, Galea G
    Healthy China 2030: an opportunity for tobacco control.
    Lancet. 2019;394:1123-1125.
    PubMed    


  22. ZHOU M, Wang H, Zeng X, Yin P, et al
    Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    Lancet. 2019;394:1145-1158.
    PubMed     Abstract available


  23. HOPKINSON NS, Arnott D, Voulvoulis N
    Environmental consequences of tobacco production and consumption.
    Lancet. 2019;394:1007-1008.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Smoking is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: